Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11739-017-1645-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Digital Health Innovations to Catalyze the Transition to Value-Based Health Care.
JMIR Med Inform
January 2025
Department of Public Administration, Law School, Hangzhou City University, Hangzhou, China.
The health care industry is currently going through a transformation due to the integration of technologies and the shift toward value-based health care (VBHC). This article explores how digital health solutions play a role in advancing VBHC, highlighting both the challenges and opportunities associated with adopting these technologies. Digital health, which includes mobile health, wearable devices, telehealth, and personalized medicine, shows promise in improving diagnostic accuracy, treatment options, and overall health outcomes.
View Article and Find Full Text PDFRecovery experiences among mental health service users going through the Balancing Everyday Life intervention - A deductive qualitative study.
Scand J Occup Ther
January 2025
Department of Health Sciences, Mental Health, Activity and Participation (MAP) group, Lund University, Sweden.
Background: The occupational therapy intervention Balancing Everyday Life (BEL) aims to support mental health service users towards improved occupational balance and personal recovery. Yet, no research has specifically addressed recovery experiences among BEL participants.
Aim: To investigate how the recovery process was experienced by mental health services users who had participated in BEL.
Personalising dietary advice for disease prevention: concepts and experiences.
Pflugers Arch
January 2025
School of Life Sciences, Technical University of Munich, 85354, Freising, Germany.
Personalised nutrition (PN) as a new endeavour emerged in the background of the human genome project with the ease to analyse genetic heterogeneity. First commercial offers with recommendations for diet and lifestyle changes, usually based on a few polymorphisms, entered markets soon after the presentation of the human genome blueprint. Although PN has seen many attempts, meanwhile, with the inclusion of other biomedical measures such as microbiome and/or continuous glucose monitoring, scientific assessments of such approaches in various settings revealed limited success.
View Article and Find Full Text PDFRefining High-Risk Multiple Myeloma: Advancements in Genomic, Clinical, and Prognostic Criteria.
Mediterr J Hematol Infect Dis
January 2025
Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.
Multiple myeloma (MM) is a heterogeneous disease, with MM patients experiencing different clinical outcomes depending on the disease's biological features. Novel insights into the molecular mechanisms of MM have led to the introduction of sophisticated drugs, which dramatically improved patient treatment and survival. To date, young patients with newly diagnosed MM could experience a median overall survival (OS) of 10 years.
View Article and Find Full Text PDFNET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations.
Endocr Oncol
January 2024
OCDEM, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital, Oxford, UK.
Current models for the study of neuroendocrine tumours (NETs) are severely limited. While (e.g.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!